Atorvastatin Calcium Tablets Recalled for Manufacturing Process Deviations
Preferred Pharmaceuticals is recalling Atorvastatin Calcium Tablets (10 mg) distributed nationwide due to manufacturing process deviations identified at Accord Healthcare. Affected lot numbers are A0523D, F14220, and J0622Q.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving manufacturing process deviations with no reported illnesses or injuries. No specific confirmed hazard is identified in the source, making this a precautionary quality-based recall.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling Atorvastatin Calcium Tablets, USP, 10 mg (90-count bottles) distributed nationwide. The affected product is manufactured by Accord Healthcare, Inc. (Durham, NC) and is identified by lot numbers A0523D (expiration 5/31/2024), F14220 (expiration 7/31/2023), and J0622Q (expiration 1/31/2024), with NDC 68788-7630-9.
The recall was initiated due to manufacturing process deviations identified at the manufacturing facility following an FDA inspection.
This product is an Rx-only prescription medication distributed nationwide across the United States. A total of 158 bottles are affected by this recall.
Patients currently taking this medication should consult their healthcare provider or pharmacist regarding this recall.
The recalled product
- Product
- Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 158
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: A0523D
- Exp 5/31/2024
- F14220
- Exp 7/31/2023
- J0622Q
- Exp 1/31/2024.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 17 recalled by Preferred Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Preferred Pharmaceuticals, Inc.
See all →- ModeratePreferred Pharmaceuticals Recalls Lidocaine Ointment Due to Content Uniformity Failures
FDA (Drugs) · 2026-10-14
- HighGeri-Care artificial tears lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- ModerateOndansetron blister packs recalled because tablets are falling out
FDA (Drugs) · 2025-12-24
- ModerateClindamycin Hydrochloride Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-07
- HighIbuprofen Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-09-04
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14
Similar recalls
- ModeratePrescription Drug Recall: Atorvastatin Calcium Tablets for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- HighAtorvastatin Calcium tablets recalled due to manufacturing practice deviations
FDA (Drugs) · 2023-03-08
- HighAtorvastatin Calcium 80 mg tablets recalled for manufacturing quality deviations
FDA (Drugs) · 2023-03-08
- ModerateAtorvastatin Calcium Tablets Recalled for Manufacturing Quality Violations
FDA (Drugs) · 2023-05-03
- HighPrescription Drug Simvastatin Recalled for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- ModerateAtorvastatin 10 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22